{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:08:37Z","timestamp":1765040917082},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00104-019-0993-2","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T09:02:48Z","timestamp":1564390968000},"page":"652-659","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Empfehlungen zur perioperativen Anwendung von Metamizol","Recommendations for the perioperative use of dipyrone"],"prefix":"10.1007","volume":"90","author":[{"given":"U. M.","family":"Stamer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Stammschulte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Erlenwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Koppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Freys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Mei\u00dfner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ahrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.-M.","family":"Brede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lindig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Heitfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Lux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pauli-Magnus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pogatzki-Zahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Quaisser-Kimpfbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Ringeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Rittner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ulma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wirz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"key":"993_CR1","volume-title":"AWMF-Regelwerk Leitlinien: Graduierung der Empfehlungen","author":"AWMF","year":"2019","unstructured":"AWMF (2019) AWMF-Regelwerk Leitlinien: Graduierung der Empfehlungen. www.awmf.org\/leitlinien\/awmf-regelwerk\/ll-entwicklung\/awmf-regelwerk-03-leitlinienentwicklung\/ll-entwicklung-graduierung-der-empfehlungen.html . Zugegriffen: 16. M\u00e4rz 2019"},{"issue":"6","key":"993_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/joim.12467","volume":"279","author":"CL Andersen","year":"2016","unstructured":"Andersen\u00a0CL, Tesfa\u00a0D, Siersma\u00a0VD, Sandholdt\u00a0H, Hasselbalch\u00a0H, Bjerrum\u00a0OW, Felding\u00a0P, Lind\u00a0B, de Fine Olivarius\u00a0N, Palmblad\u00a0J (2016) Prevalence and clinical significance of neutropenia discovered in routine complete blood cell counts: A\u00a0longitudinal study. J\u00a0Intern Med 279(6):566\u2013575","journal-title":"J Intern Med"},{"key":"993_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn\u00a0F, Konzen\u00a0C, Garbe\u00a0E (2007) Systematic review: Agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146:657\u2013665","journal-title":"Ann Intern Med"},{"key":"993_CR4","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0895-4356(98)00076-6","volume":"51","author":"SE Andrade","year":"1998","unstructured":"Andrade\u00a0SE, Martinez\u00a0C, Walker\u00a0AM (1998) Comparative safety evaluation of non-narcotic analgesics. J\u00a0Clin Epidemiol 51:1357\u20131365","journal-title":"J Clin Epidemiol"},{"key":"993_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jcpt.12422","volume":"41","author":"S Andrade","year":"2016","unstructured":"Andrade\u00a0S, Bartels\u00a0DB, Lange\u00a0R, Sandford\u00a0L, Gurwitz\u00a0J (2016) Safety of metamizole: A\u00a0systematic review of the literature. J\u00a0Clin Pharm Ther 41:459\u2013477","journal-title":"J Clin Pharm Ther"},{"key":"993_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/MOH.0b013e3282f15fb9","volume":"15","author":"E Andr\u00e8s","year":"2008","unstructured":"Andr\u00e8s\u00a0E, Maloisel\u00a0F (2008) Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol 15:15\u201321","journal-title":"Curr Opin Hematol"},{"key":"993_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2010.08104.x","volume":"150","author":"E Andr\u00e8s","year":"2010","unstructured":"Andr\u00e8s\u00a0E, Maloisel\u00a0F, Zimmer\u00a0J (2010) The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis. Br J Haematol 150:3\u20138","journal-title":"Br J Haematol"},{"key":"993_CR8","first-page":"1758","volume":"108","author":"Arzneimittelkommission der Deutschen \u00c4rzteschaft","year":"2011","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft (2011) Aganulozytose nach Metamizol \u2013 selten, aber h\u00e4ufiger als gedacht. Dtsch \u00c4rztebl 108:1758\u20131759","journal-title":"Dtsch \u00c4rztebl"},{"key":"993_CR9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.21307\/immunohematology-2019-103","volume":"30","author":"BR Curtis","year":"2014","unstructured":"Curtis\u00a0BR (2014) Drug-induced immune neutropenia\/agranulocytosis. Immunohematology 30:95\u2013101","journal-title":"Immunohematology"},{"key":"993_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/thy.1999.9.29","volume":"9","author":"S Fukata","year":"1999","unstructured":"Fukata\u00a0S, Kuma\u00a0K, Sugawara\u00a0M (1999) Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: A\u00a0prospective study. Thyroid 9:29\u201331","journal-title":"Thyroid"},{"key":"993_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1517\/14740338.6.3.323","volume":"6","author":"E Garbe","year":"2007","unstructured":"Garbe\u00a0E (2007) Non-chemotherapy drug-induced agranulocytosis. Expert Opin Drug Saf 6:323\u2013335","journal-title":"Expert Opin Drug Saf"},{"key":"993_CR12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-0043-115329","volume":"53","author":"FA Gonnert","year":"2018","unstructured":"Gonnert\u00a0FA, Mei\u00dfner\u00a0W (2018) Kasuistik: Metamizol-induzierte Agranulozytose. An\u00e4sthesiol Intensivmed Notfallmed Schmerzther 53:388\u2013394","journal-title":"An\u00e4sthesiol Intensivmed Notfallmed Schmerzther"},{"key":"993_CR13","first-page":"46","volume":"40","author":"E Haen","year":"2013","unstructured":"Haen\u00a0E, H\u00f6ffler\u00a0D, Stammschulte\u00a0T (2013) T\u00f6dliche Agranulozytose unter Novaminsulfon \u2013 aus Fehlern lernen. Arzneiverordn Prax 40:46\u201347","journal-title":"Arzneiverordn Prax"},{"issue":"48","key":"993_CR14","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.4414\/smf.2017.03098","volume":"17","author":"M Haschke","year":"2017","unstructured":"Haschke\u00a0M, Liechti\u00a0ME (2017) Metamizol: Nutzen und Risiken im Vergleich zu Paracetamol und NSAR. Schweiz Med Forum 17(48):1067\u20131073. https:\/\/doi.org\/10.4414\/smf.2017.03098","journal-title":"Schweiz Med Forum"},{"key":"993_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00228-013-1618-1","volume":"70","author":"M Huber","year":"2014","unstructured":"Huber\u00a0M, Andersohn\u00a0F, Bronder\u00a0E, Klimpel\u00a0A, Thomae\u00a0M, Konzen\u00a0C, Meyer\u00a0O, Salama\u00a0A, Schrezenmeier\u00a0H, Hildebrandt\u00a0M, Spath-Schwalbe\u00a0E, Gr\u00fcneisen\u00a0A, Kreutz\u00a0R, Garbe\u00a0E (2014) Drug-induced agranulocytosis in the Berlin case-control surveillance study. Eur J Clin Pharmacol 70:339\u2013345","journal-title":"Eur J Clin Pharmacol"},{"key":"993_CR16","first-page":"28","volume":"5","author":"J K\u00f6bberling","year":"2017","unstructured":"K\u00f6bberling\u00a0J, von Alpen\u00a0R (2017) Metamizol und Agranulozytose \u2013 Aufkl\u00e4rungspflicht. Rheinisches \u00c4rztebl 5:28\u201329","journal-title":"Rheinisches \u00c4rztebl"},{"issue":"3","key":"993_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/papr.12467","volume":"17","author":"J Konijnenbelt-Peters","year":"2017","unstructured":"Konijnenbelt-Peters\u00a0J, van der Heijden\u00a0C, Ekhart\u00a0C, Bos\u00a0J, Bruhn\u00a0J, Kramers\u00a0C (2017) Metamizole (dipyrone) as an alternative agent in postoperative analgesia in patients with contraindications for nonsteroidal anti-inflammatory drugs. Pain Pract 17(3):402\u2013408","journal-title":"Pain Pract"},{"key":"993_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0140-6736(91)90744-A","volume":"337","author":"JR Laporte","year":"1991","unstructured":"Laporte\u00a0JR, Carne\u00a0X, Vidal\u00a0X, Moreno\u00a0V, Juan\u00a0J (1991) Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Catalan Countries Study on Upper Gastrointestinal Bleeding. Lancet 337:85\u201389","journal-title":"Lancet"},{"key":"993_CR19","first-page":"CD003039","volume":"10","author":"R Mhaskar","year":"2014","unstructured":"Mhaskar\u00a0R, Clark\u00a0OA, Lyman\u00a0G, Engel Ayer Botrel\u00a0T, Morganti Paladini\u00a0L, Djulbegovic\u00a0B (2014) Colony-stimulating factors for chemotherapy-induced febrile neutropenia. Cochrane Database Syst Rev 10:CD3039","journal-title":"Cochrane Database Syst Rev"},{"key":"993_CR20","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/ejp.1194","volume":"22","author":"L Reist","year":"2018","unstructured":"Reist\u00a0L, Erlenwein\u00a0J, Meissner\u00a0W, Stammschulte\u00a0T, St\u00fcber\u00a0F, Stamer\u00a0UM (2018) Dipyrone is the preferred non-opioid analgesic for the treatment of acute and chronic pain. A survey of clinical practice in German speaking countries. Eur J Pain 22:1103\u20131112","journal-title":"Eur J Pain"},{"issue":"28","key":"993_CR21","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","volume":"33","author":"TJ Smith","year":"2015","unstructured":"Smith\u00a0TJ, Bohlke\u00a0K, Lyman\u00a0GH et\u00a0al (2015) Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update. J\u00a0Clin Oncol 33(28):3199\u20133212","journal-title":"J Clin Oncol"},{"key":"993_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00482-016-0160-3","volume":"31","author":"UM Stamer","year":"2017","unstructured":"Stamer\u00a0UM, Gundert-Remy\u00a0U, Biermann\u00a0E, Erlenwein\u00a0J, Meissner\u00a0W, Wirz\u00a0S, Stammschulte\u00a0T (2017) Metamizol: \u00dcberlegungen zum Monitoring zur fr\u00fchzeitigen Diagnose einer Agranulozytose. Schmerz 31:5\u201313","journal-title":"Schmerz"},{"key":"993_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.acpain.2007.08.025","volume":"9","author":"UM Stamer","year":"2007","unstructured":"Stamer\u00a0UM, Soehle\u00a0M, Park\u00a0TW, Fischer\u00a0M, St\u00fcber\u00a0F (2007) Anaphylactic reaction after intravenous dipyrone. Acute Pain 9:221\u2013227","journal-title":"Acute Pain"},{"key":"993_CR24","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00228-015-1895-y","volume":"71","author":"T Stammschulte","year":"2015","unstructured":"Stammschulte\u00a0T, Ludwig\u00a0WD, Muhlbauer\u00a0B, Bronder\u00a0E, Gundert-Remy\u00a0U (2015) Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990\u20132012. Eur J Clin Pharmacol 71:1129\u20131138","journal-title":"Eur J Clin Pharmacol"},{"key":"993_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1024\/1661-8157\/a001916","volume":"104","author":"E Zeiner","year":"1994","unstructured":"Zeiner\u00a0E, Blaser\u00a0LS, Tisljar\u00a0K, Heim\u00a0D, Taegtmeyer\u00a0A (1994) Fatale Agranulozytosis nach Metamizol-Reexposition. Praxis 104:151\u2013154","journal-title":"Praxis"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-019-0993-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-019-0993-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-019-0993-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T12:51:09Z","timestamp":1721566269000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-019-0993-2"}},"subtitle":["Expertenempfehlung des Arbeitskreises Akutschmerz der Deutschen Schmerzgesellschaft, des Wissenschaftlichen Arbeitskreises Schmerzmedizin der Deutschen Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin und der Chirurgischen Arbeitsgemeinschaft Akutschmerz der Deutschen Gesellschaft f\u00fcr Chirurgie unter Beteiligung von Vertretern der Arzneimittelkommission der deutschen \u00c4rzteschaft","Expert recommendation of the working group on acute pain of the German Pain Society, the scientific working group on pain medicine of the German Society for Anesthesiology and Intensive Care Medicine and the surgical working group on acute pain of the German Society for Surgery with participation of representatives of the Drug Commission of the German Medical Association"],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1007\/s00104-019-0993-2","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"29 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Dusch erhielt Vortragshonorare von Gr\u00fcnenthal. J.\u00a0Erlenwein erhielt Vortragshonorare von Braun Melsungen und Gr\u00fcnenthal. S.\u00a0Freys erhielt Honorare (Vortr\u00e4ge, Advisory Board) von actrevo und Gr\u00fcnenthal. W.\u00a0Mei\u00dfner erhielt Honorare (Vortr\u00e4ge, Advisory Boards) von Bionorica, BioQ Pharma, Gr\u00fcnenthal, Menarini, Mundipharma International, Sanofi, Tilray, und TAD. E.\u00a0Pogatzki-Zahn erhielt Honorare (Vortr\u00e4ge und Advisory Boards) von AcelRX, Fresenius Kabi, MSD, Gr\u00fcnenthal, MERCK, Mundipharma, Mundipharma International, Sharp & Dohme GmbH, The Medicines Company sowie Studienunterst\u00fctzung von Mundipharma und Gr\u00fcnenthal. C.\u00a0Quaisser-Kimpfbeck erhielt ein Honorar (Advisory Board) von Gr\u00fcnenthal. H.\u00a0Rittner erhielt Forschungsgelder von Gr\u00fcnenthal. U.\u00a0Stamer erhielt Vortragshonorare von Gr\u00fcnenthal und Sintetica. S.\u00a0Wirz erhielt Honorare (Vortr\u00e4ge, Advisory Board) von AstraZeneca, Gr\u00fcnenthal, Kyowa Kirin und Mundipharma. T.\u00a0Stammschulte, W.\u00a0Koppert, P.\u00a0Ahrens, E.-M.\u00a0Brede, M.\u00a0Lindig, S.\u00a0Heitfeld, E.\u00a0Hoffmann, E.A.\u00a0Lux, E.\u00a0M\u00fcller, D.\u00a0Pauli-Magnus, U.\u00a0Ringeler und J.\u00a0Ulma geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}